These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1593955)
1. 31P MRS as an early prognostic indicator of patient response to chemotherapy. Redmond OM; Stack JP; O'Connor NG; Carney DN; Dervan PA; Hurson BJ; Ennis JT Magn Reson Med; 1992 May; 25(1):30-44. PubMed ID: 1593955 [TBL] [Abstract][Full Text] [Related]
2. Application of 31P MR spectroscopy to the brain tumors. Ha DH; Choi S; Oh JY; Yoon SK; Kang MJ; Kim KU Korean J Radiol; 2013; 14(3):477-86. PubMed ID: 23690717 [TBL] [Abstract][Full Text] [Related]
3. 31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Kettelhack C; Wickede Mv; Vogl T; Schneider U; Hohenberger P Cancer; 2002 Mar; 94(5):1557-64. PubMed ID: 11920514 [TBL] [Abstract][Full Text] [Related]
4. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Jalan R; Sargentoni J; Coutts GA; Bell JD; Rolles K; Burroughs AK; Taylor Robinson SD Gut; 1996 Jul; 39(1):141-6. PubMed ID: 8881826 [TBL] [Abstract][Full Text] [Related]
5. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T. Krikken E; van der Kemp WJM; van Diest PJ; van Dalen T; van Laarhoven HWM; Luijten PR; Klomp DWJ; Wijnen JP NMR Biomed; 2019 Jun; 32(6):e4086. PubMed ID: 30924571 [TBL] [Abstract][Full Text] [Related]
6. Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31P magnetic resonance spectroscopy. Redmond OM; Bell E; Stack JP; Dervan PA; Carney DN; Hurson B; Ennis JT Magn Reson Med; 1992 Oct; 27(2):226-37. PubMed ID: 1461110 [TBL] [Abstract][Full Text] [Related]
7. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715 [TBL] [Abstract][Full Text] [Related]
8. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. Vaupel P; Okunieff P; Kallinowski F; Neuringer LJ Radiat Res; 1989 Dec; 120(3):477-93. PubMed ID: 2594969 [TBL] [Abstract][Full Text] [Related]
9. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients]. Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264 [TBL] [Abstract][Full Text] [Related]
10. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971 [TBL] [Abstract][Full Text] [Related]
11. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors]. Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555 [TBL] [Abstract][Full Text] [Related]
12. [Assessment of functional severity on in vivo hepatic 31P-MRS in diffuse hepatic disease: comparative studies with 99mTc-GSA]. Matoba M; Tonami H; Yokota H; Higashi K; Yamamoto I Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jul; 60(8):439-44. PubMed ID: 10965750 [TBL] [Abstract][Full Text] [Related]
13. In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia. Vaupel P; Okunieff P; Neuringer LJ Int J Hyperthermia; 1990; 6(1):15-31. PubMed ID: 2299228 [TBL] [Abstract][Full Text] [Related]
14. In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. Möller HE; Vermathen P; Rummeny E; Wörtler K; Wuisman P; Rössner A; Wörmann B; Ritter J; Peters PE NMR Biomed; 1996 Dec; 9(8):347-58. PubMed ID: 9176889 [TBL] [Abstract][Full Text] [Related]
15. 31P-magnetic resonance spectroscopy (31P-MRS) of human allografts after renal transplantation. Klemm A; Rzanny R; Fünfstück R; Werner W; Schubert J; Kaiser WA; Stein G Nephrol Dial Transplant; 1998 Dec; 13(12):3147-52. PubMed ID: 9870480 [TBL] [Abstract][Full Text] [Related]
16. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241 [TBL] [Abstract][Full Text] [Related]
18. The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy. Smith SR; Martin PA; Davies JM; Edwards RH; Stevens AN Br J Cancer; 1990 Mar; 61(3):485-90. PubMed ID: 2328218 [TBL] [Abstract][Full Text] [Related]
19. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors. Park JM; Park JH Korean J Radiol; 2001; 2(2):80-6. PubMed ID: 11752975 [TBL] [Abstract][Full Text] [Related]
20. 31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy. Koutcher JA; Ballon D; Graham M; Healey JH; Casper ES; Heelan R; Gerweck LE Magn Reson Med; 1990 Oct; 16(1):19-34. PubMed ID: 2175008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]